These Numbers Could Change Investor Views For Dyne Therapeutics Inc (NASDAQ: DYN)
Currently, there are 101.75M common shares owned by the public and among those 77.75M shares have been available to trade. The company’s stock has a 5-day price change of -3.26% and -57.76% over the past three months. DYN shares are trading -41.98% year to date (YTD), with the 12-month market performance down to -19.40% lower. […]
Dyne Therapeutics Inc (DYN): A Great Stock For Handling Current Market Conditions?
Citadel Advisors LLC recently announced the acquisition of new stake in Dyne Therapeutics Inc (NASDAQ:DYN). The institutional investor has increased its shareholding in the Healthcare company by 11.54% to 3.02 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 4.92% valued currently at $33.44 million. In addition, BlackRock […]
